These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29786563)

  • 1. Cell-based liver therapies: past, present and future.
    Iansante V; Chandrashekran A; Dhawan A
    Philos Trans R Soc Lond B Biol Sci; 2018 Jul; 373(1750):. PubMed ID: 29786563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based therapies for metabolic liver disease.
    Enns GM; Millan MT
    Mol Genet Metab; 2008; 95(1-2):3-10. PubMed ID: 18640065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments.
    Cantz T; Sharma AD; Ott M
    Stem Cells; 2015 Apr; 33(4):1055-62. PubMed ID: 25524146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Cell Sources to Adult Hepatocytes for Hepatic Cell Therapy.
    Pareja E; Gómez-Lechón MJ; Tolosa L
    Methods Mol Biol; 2017; 1506():17-42. PubMed ID: 27830543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of hepatocyte-like cell therapy from stem cells.
    Saito Y; Ikemoto T; Morine Y; Shimada M
    Surg Today; 2021 Mar; 51(3):340-349. PubMed ID: 32754843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Application of Pluripotent Stem Cells: An Alternative Cell-Based Therapy for Treating Liver Diseases?
    Tolosa L; Pareja E; Gómez-Lechón MJ
    Transplantation; 2016 Dec; 100(12):2548-2557. PubMed ID: 27495745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human hepatocyte transplantation for liver disease: current status and future perspectives.
    Iansante V; Mitry RR; Filippi C; Fitzpatrick E; Dhawan A
    Pediatr Res; 2018 Jan; 83(1-2):232-240. PubMed ID: 29149103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell therapy for liver disease: From liver transplantation to cell factory.
    Forbes SJ; Gupta S; Dhawan A
    J Hepatol; 2015 Apr; 62(1 Suppl):S157-69. PubMed ID: 25920085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell therapies for liver diseases.
    Yu Y; Fisher JE; Lillegard JB; Rodysill B; Amiot B; Nyberg SL
    Liver Transpl; 2012 Jan; 18(1):9-21. PubMed ID: 22140063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells.
    Chen C; Soto-Gutierrez A; Baptista PM; Spee B
    Gastroenterology; 2018 Apr; 154(5):1258-1272. PubMed ID: 29428334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-based therapies of liver diseases: age-related challenges.
    Yarygin KN; Lupatov AY; Kholodenko IV
    Clin Interv Aging; 2015; 10():1909-24. PubMed ID: 26664104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy in chronic liver disease.
    Nicolas CT; Wang Y; Nyberg SL
    Curr Opin Gastroenterol; 2016 May; 32(3):189-94. PubMed ID: 26950359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.
    Hansel MC; Davila JC; Vosough M; Gramignoli R; Skvorak KJ; Dorko K; Marongiu F; Blake W; Strom SC
    Curr Protoc Toxicol; 2016 Feb; 67():14.13.1-14.13.27. PubMed ID: 26828329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem Cell-Based Therapies for Liver Diseases: An Overview and Update.
    Wang J; Sun M; Liu W; Li Y; Li M
    Tissue Eng Regen Med; 2019 Apr; 16(2):107-118. PubMed ID: 30989038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present and Future Perspectives of Using Human-Induced Pluripotent Stem Cells and Organoid Against Liver Failure.
    Kuse Y; Taniguchi H
    Cell Transplant; 2019 Dec; 28(1_suppl):160S-165S. PubMed ID: 31838891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic progenitor cells.
    Sangan CB; Tosh D
    Cell Tissue Res; 2010 Nov; 342(2):131-7. PubMed ID: 20957497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells for Cellular Medicine.
    Deguchi S; Takayama K; Mizuguchi H
    Biol Pharm Bull; 2020; 43(4):608-615. PubMed ID: 32238703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases.
    Cernigliaro V; Peluso R; Zedda B; Silengo L; Tolosano E; Pellicano R; Altruda F; Fagoonee S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quest for liver progenitor cells: a practical point of view.
    Dollé L; Best J; Mei J; Al Battah F; Reynaert H; van Grunsven LA; Geerts A
    J Hepatol; 2010 Jan; 52(1):117-29. PubMed ID: 19913937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver regenerative medicine: advances and challenges.
    Chistiakov DA
    Cells Tissues Organs; 2012; 196(4):291-312. PubMed ID: 22572238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.